Pantoprazol Viatris (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Viatris, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat acid‑related gastrointestinal conditions in adults. GNH USA supplies Pantoprazol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Pantoprazol Viatris, a proton pump inhibitor, is indicated for conditions involving excess gastric acid secretion. - Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation by lowering stomach acidity. - Erosive esophagitis: promotes healing of inflamed esophageal tissue caused by acid exposure. - Zollinger‑Ellison syndrome: controls hypersecretion of gastric acid associated with gastrin‑producing tumors. - Peptic ulcer disease: supports ulcer healing and prevents recurrence by maintaining a less acidic gastric environment.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: occasional feeling of queasiness after dosing. - Abdominal pain: mild discomfort in the stomach region.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle weakness, irregular heartbeat. - Elevated liver enzymes: signs of hepatic stress on laboratory testing. - Stevens‑Johnson syndrome: severe skin rash and mucosal involvement. - Acute pancreatitis: sudden upper abdominal pain radiating to the back.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium levels: long‑term use can lead to hypomagnesemia. - Use with caution in hepatic impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Consider dose reduction in elderly patients: increased sensitivity to adverse effects. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Pantoprazol may interact with several medications, requiring attention to avoid reduced efficacy or increased toxicity. Major Interactions (Avoid): - Ketoconazole or itraconazole: decreased absorption due to reduced gastric acidity. - Atazanavir: markedly reduced plasma concentrations, compromising antiviral effect. Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Digoxin: possible rise in serum levels, observe for signs of toxicity. - Methotrexate (high dose): reduced renal clearance, monitor renal function and drug levels.